EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms

Sanghak Lee, Kei-Anne Garcia Baritugo, Han-Soo Kim, Hyeyoung Lee, Sook Won Ryu iD, Soo-Young Kim, Chae Hoon Lee, Young Ree Kim, Jeong Hwan Shin iD, Jayoung Kim iD, Gi-Ho Sung

Journal of Fungi · 20.01.2026 · 12 (1) · 76

DOI: 10.3390/jof12010076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 20.01.2026. Verfasst von Sanghak Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Institute of Mycological Resource, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon 22711, Re…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fungi Specialized Pathogen Resource Bank under National Culture Collection for Pathogens (NCCP) of the Korea Disease Control and Prevention, Fungi Specialized Pathogen Resource Bank under the National Culture Collection for Pathogens (NCCP) of the Korea Disease Control and Prevention Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candidozyma auris (formerly Candida auris) is an emerging multidrug-resistant fungal pathogen with confirmed cases in over 30 countries. Although whole-genome sequencing (WGS) analysis defined distinct clades during characterization of underlying genetic mechanism behind multidrug resistance, Clade II remains under-evaluated. In this study, a three-level comparative genomic strategy (Global, Clade, Phenotype) was employed by integration of unbiased genome-wide comparative SNP screening (GATK v4.1.9.0), targeted BLAST profiling (BLAST+ v2.17.0), and in silico protein analysis (ColabFold v1.5.5; DynaMut2 v2.0) for systematic evaluation of mechanisms of antifungal resistance in thirty-nine Clade II C. auris clinical isolates and fourteen reference strains. Global and clade-level analyses confirmed that all the clinical isolates belong to Clade II, according to phylogenetic clustering and mating type locus (MTL) conservation. At the phenotype level, a distinct subclade of fluconazole-resistant mutants was identified to have a heterogenous network of mutations in seven key enzymes associated with cell membrane dynamics and the metabolic stress response. Among these, four core mutations (TAC1B, CAN2, NIC96, PMA1) were confirmed as functional drivers based on strict criteria during multitier in silico protein analysis: cross-species conservation, surface exposure, active site proximity, thermodynamic stability, and protein interface interaction. On the other hand, three high-level fluconazole-resistant clinical isolates (≥128 μg/mL) that lacked these functional drivers were subjected to comprehensive subtractive genomic profiling analysis. The absence of coding mutations in validated resistance drivers, yeast orthologs, and convergent variants suggests that there is an alternative novel non-coding or regulatory mechanism behind fluconazole resistance. These findings highlight Clade II’s evolutionary divergence into two distinct trajectories towards the development of a high level of fluconazole resistance: canonical protein alteration versus regulatory modulation.

Schlagwörter

Stichwörter der Autor:innen

Candida aurisCandidozyma aurisclade IIcomparative genomicsfluconazole resistancein silico structural modelingphylogenomicsregulatory modulationwhole-genome sequencing

Autor:innen und Institutionen

  • Biomedical Institute of Mycological Resource, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon 22711, Republic of Korea.
  • Department of Biomedical Sciences, Graduate School, Catholic Kwandong University, Gangneung 25601, Republic of Korea.
  • Department of Laboratory Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon 22711, Republic of Korea.
  • Department of Laboratory Medicine, School of Medicine, Kangwon National University, Chuncheon 24331, Republic of Korea.
  • Department of Laboratory Medicine, College of Medicine, Catholic University of Korea, St. Vincent's Hospital, Suwon 16247, Republic of Korea.
  • Department of Laboratory Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.

ORCID-Profile: Sook Won Ryu, Jeong Hwan Shin, Jayoung Kim

Förderung

  • Fungi Specialized Pathogen Resource Bank under National Culture Collection for Pathogens (NCCP) of the Korea Disease Control and Prevention
  • Fungi Specialized Pathogen Resource Bank under the National Culture Collection for Pathogens (NCCP) of the Korea Disease Control and Prevention Agency

Zitieren

APA

Lee, S., Baritugo, K. G., Kim, H. S., Lee, H., Ryu, S. W., Kim, S. Y., Lee, C. H., Kim, Y. R., Shin, J. H., Kim, J., & Sung, G. H. (2026). Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms. Journal of Fungi, 12(1), 76. https://doi.org/10.3390/jof12010076

Vancouver

Lee S, Baritugo KG, Kim HS, Lee H, Ryu SW, Kim SY, et al. Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms. Journal of Fungi. 2026;12(1):76. doi:10.3390/jof12010076

BibTeX
@article{Lee2026,
  author = {Lee, Sanghak and Baritugo, Kei-Anne Garcia and Kim, Han-Soo and Lee, Hyeyoung and Ryu, Sook Won and Kim, Soo-Young and Lee, Chae Hoon and Kim, Young Ree and Shin, Jeong Hwan and Kim, Jayoung and Sung, Gi-Ho},
  title = {Genomic Insights into Candidozyma auris Clade II: Comparative Phylogenomics and Structural Validation of Fluconazole Resistance Mechanisms},
  journal = {Journal of Fungi},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {76},
  doi = {10.3390/jof12010076}
}
Kostenlos starten →